119 related articles for article (PubMed ID: 8070118)
1. Percutaneous nephrostomy in patients with advanced or recurrent cervical cancer.
Gadducci A; Madrigali A; Facchini V; Fioretti P
Clin Exp Obstet Gynecol; 1994; 21(2):71-3. PubMed ID: 8070118
[TBL] [Abstract][Full Text] [Related]
2. Impact of palliative urinary diversion by percutaneous nephrostomy drainage and ureteral stenting among patients with advanced cervical cancer and obstructive uropathy: a prospective cohort.
Lapitan MC; Buckley BS
J Obstet Gynaecol Res; 2011 Aug; 37(8):1061-70. PubMed ID: 21481096
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous nephrostomy in gynecologic oncology patients.
Soper JT; Blaszczyk TM; Oke E; Clarke-Pearson D; Creasman WT
Am J Obstet Gynecol; 1988 May; 158(5):1126-31. PubMed ID: 2453117
[TBL] [Abstract][Full Text] [Related]
4. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
Dhani FK; Daryanto B; Seputra KP
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
[TBL] [Abstract][Full Text] [Related]
5. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
Tan S; Tao Z; Bian X; Zhao Y; Wang N; Chen X; Wu B
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():99-103. PubMed ID: 31484100
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous nephrostomy in the management of advanced and terminal-stage gynecologic malignancies: outcome and complications.
Plesinac-Karapandzic V; Masulovic D; Markovic B; Djuric-Stefanovic A; Plesinac S; Vucicevic D; Milovanovic Z; Milosevic Z
Eur J Gynaecol Oncol; 2010; 31(6):645-50. PubMed ID: 21319508
[TBL] [Abstract][Full Text] [Related]
7. Palliative percutaneous nephrostomy in recurrent cervical cancer: a retrospective analysis of 50 consecutive cases.
Dienstmann R; da Silva Pinto C; Pereira MT; Small IA; Ferreira CG
J Pain Symptom Manage; 2008 Aug; 36(2):185-90. PubMed ID: 18395404
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial.
Mokhmalji H; Braun PM; Martinez Portillo FJ; Siegsmund M; Alken P; Köhrmann KU
J Urol; 2001 Apr; 165(4):1088-92. PubMed ID: 11257644
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous nephrostomy: its value in obstructive uropathy complicating carcinoma of cervix uterus.
Chan S; Robinson AC; Johnson RJ
Clin Oncol (R Coll Radiol); 1990 May; 2(3):156-8. PubMed ID: 2261404
[TBL] [Abstract][Full Text] [Related]
10. Improved split renal function after percutaneous nephrostomy in young adults with severe hydronephrosis due to ureteropelvic junction obstruction.
Zhang S; Zhang Q; Ji C; Zhao X; Liu G; Zhang S; Li X; Lian H; Zhang G; Guo H
J Urol; 2015 Jan; 193(1):191-5. PubMed ID: 25014578
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous nephrostomies in women with cervical cancer.
Kehoe S; Luesley DM; Budden J; Earl H
Br J Obstet Gynaecol; 1993 Mar; 100(3):283-4. PubMed ID: 8476838
[No Abstract] [Full Text] [Related]
12. Ultrasound-guided percutaneous nephrostomy in the treatment of advanced gynecologic malignancy.
Pedersen H; Juul N
Acta Obstet Gynecol Scand; 1988; 67(3):199-201. PubMed ID: 3176936
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study.
de Sousa Morais N; Pereira JP; Mota P; Carvalho-Dias E; Torres JN; Lima E
Urolithiasis; 2019 Dec; 47(6):567-573. PubMed ID: 30219938
[TBL] [Abstract][Full Text] [Related]
14. [Percutaneous nephrostomy of postrenal failure due to locally advanced uterine cervical cancer].
Shimamoto T; Tateyama H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep; 40(9):1471-4. PubMed ID: 3171275
[No Abstract] [Full Text] [Related]
15. The role of percutaneous nephrostomy in gynecologic oncology.
Mann WJ; Hatch KD; Taylor PT; Partridge EM; Orr JW; Shingleton HM
Gynecol Oncol; 1983 Dec; 16(3):393-9. PubMed ID: 6654181
[TBL] [Abstract][Full Text] [Related]
16. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival.
Patel K; Foster NR; Kumar A; Grudem M; Longenbach S; Bakkum-Gamez J; Haddock M; Dowdy S; Jatoi A
Support Care Cancer; 2015 May; 23(5):1303-9. PubMed ID: 25339620
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic and ethical problems of nephrostomy in tumor-related hydronephrosis].
Tauber R; Groos E; Zink RA
Urologe A; 1985 Nov; 24(6):320-2. PubMed ID: 2418568
[TBL] [Abstract][Full Text] [Related]
18. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer.
Emmert C; Rassler J; Köhler U
Arch Gynecol Obstet; 1997; 259(3):147-51. PubMed ID: 9187468
[TBL] [Abstract][Full Text] [Related]
19. Pelvic radiotherapy in patients with hydronephrosis in stage IIIB cancer of the cervix: renal effects and the optimal timing for urinary diversion?
Horan G; McArdle O; Martin J; Collins CD; Faul C
Gynecol Oncol; 2006 Jun; 101(3):441-4. PubMed ID: 16337996
[TBL] [Abstract][Full Text] [Related]
20. Mortality and complications associated with percutaneous nephrostomy in patients with ureteral obstruction related to advanced cervical cancer.
Cardona AF; Garzón JR; Burgos E; Abenoza LM; Cortés JA; Ramos PL
J Palliat Care; 2006; 22(4):315. PubMed ID: 17263063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
